Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy–treated mantle cell lymphoma

The outcome for patients with mantle cell lymphoma (MCL) has drastically improved with new treatments directed toward the tumor immune microenvironment, where macrophages play an important role. In MCL, the presence of M2 macrophages defined by CD163 expression in diagnostic biopsies has been associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikkarinen, Anna, Lokhande, Lavanya, Amini, Rose-Marie, Jerkeman, Mats, Porwit, Anna, Molin, Daniel, Enblad, Gunilla, Kolstad, Arne, Räty, Riikka, Hutchings, Martin, Weibull, Caroline E., Hollander, Peter, Ek, Sara, Glimelius, Ingrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506048/
https://www.ncbi.nlm.nih.gov/pubmed/37389827
http://dx.doi.org/10.1182/bloodadvances.2023010052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506048/
https://www.ncbi.nlm.nih.gov/pubmed/37389827
http://dx.doi.org/10.1182/bloodadvances.2023010052

Ejemplares similares